Global Mannitol Market

Mannitol Market Size, Share, Growth Analysis, By Form(Powder and Granules), By Application(Food Grade, Pharmaceuticals, Industrial, Surfactants and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG30H2125 | Region: Global | Published Date: April, 2024
Pages: 198 | Tables: 62 | Figures: 75

Mannitol Market Dynamics

Mannitol Market Drivers

Increasing Prevalence of Chronic Diseases

  • Mannitol is used as an active pharmaceutical ingredient (API) in several medications used to treat chronic diseases such as diabetes, heart disease, and cancer. The rising prevalence of these diseases worldwide is driving the demand for mannitol as a crucial component of these medications.

Mannitol Market Restraints

Availability of Alternative Sweeteners

  • Mannitol faces competition from other low-calorie sweeteners such as stevia, aspartame, and sucralose. The availability of these alternatives can limit the demand for mannitol in the food and beverage industry.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Mannitol Market size was valued at around USD 417.48 Million in 2022 and is expected to rise from USD 445.87 in 2023 to reach a value of USD 754.70 Million by 2031, at a CAGR of 6.8% over the forecast period (2024–2031).

The mannitol market is highly competitive with the presence of several players. The market players are focusing on developing new applications of mannitol and expanding their product portfolio. Additionally, some players are investing in research and development activities to develop new applications of mannitol and improve its properties. 'Roquette', 'Cargill, Inc.', 'Ingredion Incorporated', 'SPI Pharma', 'Merck KGaA', 'Qingdao Bright Moon Seaweed Group Co. Ltd.', 'Zhejiang Huakang Pharmaceutical Co., Ltd.', 'Vizient, Inc.', 'Hebei Huaxu Pharmaceutical Co., Ltd.', 'EMD Millipore Corporation', 'Lianmeng Chemical Co., Ltd.', 'Shouguang Tiancheng Chemical Co., Ltd.', 'Pfanstiehl, Inc.', 'CarboMer, Inc.', 'Sigma-Aldrich Corporation', 'Perstorp Holding AB', 'Medtronic plc', 'Qingdao Free Trade Zone United International Co., Ltd.', 'Dancheng Caixin Sugar Industry Co., Ltd.', 'Alfa Aesar'

Mannitol is used as an active pharmaceutical ingredient (API) in several medications used to treat chronic diseases such as diabetes, heart disease, and cancer. The rising prevalence of these diseases worldwide is driving the demand for mannitol as a crucial component of these medications.

Increasing demand from the pharmaceutical industry: Mannitol is widely used as an excipient in the pharmaceutical industry to improve the solubility and bioavailability of drugs. With the growing prevalence of chronic diseases, the demand for drugs containing mannitol as an active ingredient or excipient is increasing, driving the growth of the mannitol market.

Asia Pacific led the mannitol market, accounting for more than half of the overall market. Emerging markets like China and India accounted for a large share of the total market. Consumption in the regional market has increased as a result of rising consumer health consciousness. Diabetes is becoming more common in China as a result of the country's changing lifestyle and socioeconomic level, and this trend is expected to continue for the next eight years. However, two types of diabetes must be addressed immediately: obesity and cardiovascular disease. These factors are anticipated to increase market demand over the next eight years.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Mannitol Market

Report ID: SQMIG30H2125

$5,300
BUY NOW GET FREE SAMPLE